MR

Menday Ravibabu Swathi

Active Director Director DIN 08973067
DIN 08973067 First appointment Nov 2020 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2020
Shareholding value β€’β€’β€’β€’ Premium profile

About Menday Ravibabu Swathi

Data last updated:

Menday Ravibabu Swathi is a Director at Damish Pharma Private Limited (since 2020). The company operates in Chemicals.

DIN 08973067
Primary Designation Director
Industry Chemicals
First Appointment 25 Nov 2020
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Damish Pharma Private Limited U24299TG2020PTC146278
Director25 Nov 20202020Active

Board colleagues of Menday Ravibabu Swathi

NameDINCompanyDesignation
Damini Gupta08973068Damish Pharma Private LimitedDirector
Kattlla Naresh08973066Damish Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Damish Pharma Private Limited
Premium access

Shareholding and investment profile for Menday Ravibabu Swathi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Menday Ravibabu Swathi

Menday Ravibabu Swathi currently holds 1 directorship: Damish Pharma Private Limited (Director, since 25 Nov 2020).

Menday Ravibabu Swathi was first appointed on 25 Nov 2020 as Director at Damish Pharma Private Limited.

The current boards of Menday Ravibabu Swathi's companies include Damini Gupta (Damish Pharma Private Limited), Kattlla Naresh (Damish Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available